Science 37 (SNCE) Short Interest Ratio & Short Volume

Short interest is the volume of Science 37 shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 13,800 shares of SNCE short. 0.24% of Science 37's shares are currently sold short. Learn More on Science 37's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.24% of Science 37's floating shares are currently sold short.

Science 37 saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 13,800 shares, a decrease of 56.9% from the previous total of 32,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Science 37 currently has issued a total of 5,970,000 shares. Some of Science 37's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Science 37 currently has a public float of 5,640,000 shares.

0.24% of Science 37's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Science 37: Forian Inc. (0.68%), BeyondSpring Inc. (6.28%), Vaxart, Inc. (6.63%), EUDA Health Holdings Limited (0.12%), Lucid Diagnostics Inc. (2.68%), Black Diamond Therapeutics, Inc. (14.68%), Agenus Inc. (14.68%), Assembly Biosciences, Inc. (0.35%), Lexeo Therapeutics, Inc. (15.10%), InfuSystem Holdings, Inc. (2.68%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors Company ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Corporation ($3.13 billion), Tractor Supply Company ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks.

Short selling SNCE is an investing strategy that aims to generate trading profit from Science 37 as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Science 37 occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNCE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNCE, twice per month. The most recent reporting period available is February, 29 2024.